|
Nitrosated active pharmaceutical ingredients – lessons learned -Pub
|
|
0
|
672
|
February 7, 2023
|
|
The impact of N-nitrosamine impurities on clinical drug development -Pub
|
|
1
|
560
|
February 3, 2023
|
|
Nitrosamine Impurities -Reg Updates Publication
|
|
0
|
710
|
February 1, 2023
|
|
An update on the current status of possible roots causes of Nitrosamines
|
|
2
|
858
|
January 28, 2023
|
|
Crisis management of the mass losartan recall in a public primary healthcare institution in Singapore
|
|
0
|
299
|
January 9, 2023
|
|
FDA - A new structural similarity method to ID surrogate compounds of Nitroamines
|
|
5
|
1616
|
January 7, 2023
|
|
A substructure-based screening approach to uncover Nnitrosamines in drug substances
|
|
0
|
514
|
October 10, 2022
|
|
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines -published
|
|
0
|
354
|
September 8, 2022
|
|
NAs positive in Ames test without metabolic activation
|
|
2
|
423
|
November 29, 2022
|
|
A new study on nitrite scavengers for nitrosamine formation prevention
|
|
0
|
441
|
November 17, 2022
|
|
Predicting DNA-reactivity of N-nitrosamines: Quantum Chemical Approach
|
|
0
|
234
|
November 16, 2022
|
|
NitrosAMIDES - Should they be treated the same as Nitrosamines?
|
|
1
|
622
|
October 25, 2022
|
|
N-Nitrosamines: bacterial mutagenesis and in vitro metabolism -A MUST READ
|
|
6
|
471
|
October 13, 2022
|
|
N-Nitrosation in the absence of nitrosating agents in pharmaceuticals?
|
|
2
|
449
|
September 27, 2022
|
|
Formation of the N-nitroso Deviratives of six b-Adrenergic-blocking 'LOL'
|
|
0
|
399
|
September 22, 2022
|
|
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines
|
|
0
|
275
|
August 23, 2022
|
|
Journal of Pharmaceutical Sciences is dedicating a Special Issue to the topic of nitrosamine impurities in drugs
|
|
1
|
444
|
August 2, 2022
|
|
Disinfected water and Nitrosamines
|
|
3
|
498
|
July 22, 2022
|
|
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin‑Containing Medicines
|
|
0
|
320
|
May 6, 2022
|
|
Salmonella typhimurium are highly sensitive to detect the mutagenicity of short Alkyl-N-Nitrosamines in the Bacterial Reverse Mutation Test
|
|
0
|
177
|
May 24, 2022
|
|
EMA Nitrosamine Implementation Oversight Meeting Highlights Mar'22
|
|
0
|
352
|
March 31, 2022
|
|
CMHP meeting from January: N-nitroso-Mefanamic Acid & N-Nitroso-Folic Acid
|
|
6
|
901
|
April 25, 2022
|
|
Bacterial reverse mutation assay suitable to detect the mutagenicity of Nitrosamines
|
|
0
|
208
|
February 14, 2022
|
|
Azido Impurity Method LC-MS/MS
|
|
0
|
279
|
March 25, 2022
|
|
AZIDO Impurities Topic
|
|
3
|
840
|
March 25, 2022
|
|
IPEC Federation Position Paper on Role of Excipients in determining N-Nitrosamine Risks for Drug Products - Thoughts?
|
|
1
|
285
|
March 7, 2022
|
|
Nitrosamine Impurities - Regulatory Status
|
|
0
|
258
|
December 7, 2021
|
|
Impact of Stability and Transportation on APIs
|
|
3
|
291
|
October 13, 2021
|
|
Industry Survey USP APIs/Excipients *Closing Aug 31st*
|
|
2
|
428
|
September 16, 2021
|
|
Test methods for Nitrosamines & Azido compounds in Sartans published by Taiwan FDA
|
|
0
|
199
|
September 9, 2021
|